Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade

Prostate cancer (PCa) is the most common malignancy among Western men and the second leading-cause of cancer related deaths. For men who develop metastatic castration resistant PCa (mCRPC), survival is limited, making the identification of novel therapies for mCRPC critical. We have found that defic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Flaig, Thomas W., Salzmann-Sullivan, Maren, Su, Lih-Jen, Zhang, Zhiyong, Joshi, Molishree, Gijón, Miguel A., Kim, Jihye, Arcaroli, John J., Van Bokhoven, Adrie, Lucia, M. Scott, La Rosa, Francisco G., Schlaepfer, Isabel R.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593544/
https://ncbi.nlm.nih.gov/pubmed/28915573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17359
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars